Skip to main content
The Markets by Proactive
Go to Proactive Australia

Medical technology & services

SUDA Pharmaceuticals appoints public company specialist Phillip Hains as company secretary

The company completed a heavily oversubscribed entitlement offer to raise $3.56 million on August 5 with Baker Young as the lead manager.

SUDA Pharmaceuticals Ltd (ASX:SUD) has appointed public company specialist Philip Hains as company secretary with the change coming into effect on July 1.

Hains, who is a chartered accountant operating a specialist public practice The CFO Solution, has served the needs of several company boards and their related committees

He has more than 25 years' experience in providing businesses with accounting, administration, compliance and general management services.

Hains holds a Master of Business Administration from RMIT and a Public Practice Certificate from the Institute of Chartered Accountants.

Invaluable contributions

Joseph Ohayon, who joined the company in July 2010, held the role as company secretary from March 2011 and had been a director of the company from December 2012 until May 2019.

He has assisted in the transition of accounting and company secretarial services to The CFO Solutions and supported CEO and managing director, Dr Michael Baker, since he joined at the beginning of the year.

Ohayon will be leaving the company at the end of September.

During his time at SUDA, he has provided invaluable contributions to the company and the team at SUDA has wished him all the best for his new endeavours.